B. Riley
http://www.brileyco.comB. Riley provides investment banking services to wide range of companies, as well as research and trading ideas to individual and institutional clients.
View Older Stories View More Recent Stories
-
CareCloud Announces Pricing of Public Offering of Preferred Stock
-
Eagle Point Credit Company Inc. Announces Exercise and Closing of Overallotment Option in Offering of Notes
-
TG Therapeutics (TGTX) CEO shared data and regulatory update
-
CareCloud (MTBC) Announces Commencement of Public Offering of Preferred Stock
-
CareCloud Announces Commencement of Public Offering of Preferred Stock
-
CareCloud Announces Commencement of Public Offering of Preferred Stock
-
Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference
-
Form 424B7 B. Riley Financial, Inc.
-
Form 4 ALTA EQUIPMENT GROUP For: Jan 24 Filed by: B. Riley Financial, Inc.
-
Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
-
Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022
-
Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences
-
Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences
-
VBI Vaccines to Participate in the B. Riley Securities 2022 Oncology Investor Conference
-
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Oncology Conference
-
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Oncology Conference
-
Roivant to Present at Upcoming Investor Conferences
-
Checkpoint Therapeutics to Participate in the B. Riley Securities’ Virtual Oncology Conference
-
Checkpoint Therapeutics to Participate in the B. Riley Securities’ Virtual Oncology Conference
-
Roivant to Present at Upcoming Investor Conferences
-
SparkCognition Announces $123 Million Series D Funding and a Unicorn Valuation to Accelerate AI Adoption Across Industries
-
Kymera Therapeutics to Participate in Upcoming January and February Investor Conferences
-
Rain Therapeutics to Present at Upcoming Virtual Investor Conferences
-
Kymera Therapeutics to Participate in Upcoming January and February Investor Conferences
-
Lineage to Present at B. Riley Securities 2022 Virtual Oncology Conference on January 27, 2022
-
TG Therapeutics to Participate in the B. Riley Securities 2022 Virtual Oncology Investor Conference
-
Leap Therapeutics to Present at B. Riley Securities Oncology Investor Conference
-
Immuneering Announces Participation in Upcoming Investor Conferences
-
Immuneering Announces Participation in Upcoming Investor Conferences
-
Nouveau Monde Graphite (NMG) Files For a Proposed At-The-Market Offering
-
Form 8-K B. Riley Financial, Inc. For: Jan 18
-
Nouveau Monde Announces Filing of a Prospectus Supplement for At-The-Market Offering
-
Form 4 ALTA EQUIPMENT GROUP For: Jan 19 Filed by: B. Riley Financial, Inc.
-
Fusion Pharmaceuticals to Present at the B. Riley Securities 2022 Virtual Oncology Conference
-
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
-
Karyopharm to Present at B. Riley Securities Oncology Investor Conference
-
Cardiff Oncology to Present at the B. Riley Securities 2022 Oncology Conference
-
The Financial Marketing Institute Announces Leading Financial Services Companies in Digital Experience For 2021
-
Infinity Pharmaceuticals to Be Featured in a Fireside Chat as Part of B. Riley’s 2022 Virtual Oncology Conference
-
NGM Bio to Participate in Upcoming Investor Conferences
-
Chimerix to Present at B. Riley Virtual Oncology Conference
-
NGM Bio to Participate in Upcoming Investor Conferences
-
Curis to Present at Upcoming Healthcare Conferences
-
GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference
-
Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference
-
Syndax Announces Presentation at B. Riley Securities' 2022 Oncology Conference
-
X4 Pharmaceuticals to Present at B. Riley Securities Oncology Investor Conference
-
B. Riley Financial (RILY) Acquires FocalPoint Securities for Up to $175M
-
B. Riley Financial Announces Acquisition of FocalPoint Securities, LLC, A Leading Middle Market M&A Advisory Investment Bank
-
Gracell Biotechnologies to Participate in B Riley Securities 2022 Virtual Oncology Conference

